β1 Integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides

Journal of Immunology

Volumn 163, Issue 7, 1999, Pages 3621-3628

  Wilson, Katherine E ^a,b   Li, Zhuqing ^a   Kara, Murat ^a   Gardner, Kevin L ^a   Roberts, David D ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOGLYCAN; THROMBOSPONDIN 1;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOMA CELL LINE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T CELL LYMPHOMA;

AMINO ACID SEQUENCE; ANTIGENS, CD29; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL ADHESION; CELL NUCLEUS; DNA-BINDING PROTEINS; ETS-DOMAIN PROTEIN ELK-1; GLYCOSAMINOGLYCANS; GTP-BINDING PROTEINS; HEPARIN; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; JURKAT CELLS; LYMPHOCYTE ACTIVATION; LYMPHOMA, T-CELL; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEIN P21(RAS); P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; SULFATES; THROMBOSPONDIN 1; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TYROSINE;

EID: 0033214421     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Roberts, D. D., J. A. Sherwood, and V. Ginsburg. 1987. Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J. Cell Biol. 104: 131.
2. Murphy-Ullrich, J. E., S. Gurusiddappa, W. A. Frazier, and M. Höök. 1993. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity. J. Biol. Chem. 268:26784.
3. 3 function through integrin-associated protein. J. Cell Biol. 135:533.
4. Phan, S. H., R. G. Dillon, B. M. McGarry, and V. M. Dixit. 1989. Stimulation of fibroblast proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 163:56.
5. Majack, R. A., L. V. Goodman, and V. M. Dixit. 1988. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol. 106:415.
6. Roberts, D. D. 1996. Regulation of tumor growth and metastasis by thrombospondin-1. FASEB J. 10:1183.
7. Bornstein, P. 1992. Thrombospondins: structure and regulation of expression. FASEB J. 6:3290.
8. Mosher, D. F. 1990. Physiology of thrombospondin. Annu. Rev. Med. 41:85.
9. Schuepp, B. J., and T. W. Jungi. 1991. Thrombospondin-exposed human monocytes display augmented luminol-enhanced chemoluminescence upon receptor triggering. Biochem. Biophys. Res. Commun. 177:1087.
10. Mansfield, P. J., and S. J. Suchard. 1994. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J. Immunol. 153:4219.
11. Savill, J., N. Hogg, Y. Ren, and C. Haslett. 1992. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90:1513.
12. Pierson, B. A., K. Gupta, W.-S. Hu, and J. S. Miller. 1996. Human natural killer cell expansion is regulated by thrombospondin-mediated activation of transforming growth factor β-1 and independent accessory cell-derived contact and soluble factors. Blood 87:180.
13. Schultz-Cherry, S., and J. E. Murphy-Ullrich. 1993. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122:923.
14. Crawford, S. E., V. Stellmach, J. E. Murphy-Ullrich, S. M. F. Ribeiro, J. Lawler, R. O. Hynes, G. P. Boivin, and N. Bouck. 1998. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93:1159.
15. Lawler, J., M. Sunday, V. Thibert, M. Duquette, E. L. George, H. Rayburn, and R. O. Hynes. 1998. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia. J. Clin. Invest. 101:982.
16. Bornstein, P. 1995. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130:503.
17. Lahav, J. 1993. Thrombospondin. CRC Press, Boca Raton.
18. Guo, N. H., H. C. Krutzsch, E. Nègre, T. Vogel, D. A. Blake, and D. D. Roberts. 1992. Heparin-and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion. Proc. Natl. Acad. Sci. USA 89:3040
19. Asch, A. S., S. Silbiger, E. Heimer, and R. L. Nachman. 1992. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem. Biophys. Res. Commun. 182:1208.
20. Li, W. X., R. J. Howard, and L. L. Leung. 1993. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36. J. Biol. Chem. 268:16179.
21. Panetti, T. S., B. J. Kudryk, and D. F. Mosher. 1999. Interaction of recombinant procollagen and properdin modules of thrombospondin-1 with heparin and fibrinogen/fibrin. J. Biol. Chem. 274:430.
22. Lawler, J., R. Weinstein, and R. O. Hynes. 1988. Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J. Cell Biol. 107:2351.
23. Gao, A.-G., F. P. Lindberg, M. B. Finn, S. D. Blystone, E. J. Brown, and W. A. Frazier. 1996. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271:21.
24. Reinhold, M. I., F. P. Lindberg, G. J. Kersh, P. M. Allen, and E. J. Brown. 1997. Costimulation of T cell activation by integrin-associated protein (CD47) is an adhesion-dependent, CD28-independent signaling pathway. J. Exp. Med. 185:1.
25. Ticchioni, M., M. Deckert, F. Mary, G. Bernard, E. J. Brown, and A. Bernard. 1997. Integrin-associated protein (CD47) is a comitogenic molecule on CD3-activated human T cells. J. Immunol. 158:677.
26. 5β1 (VLA-5) integrins. J. Immunol. 151:149.
27. Ybarrondo, B., A. M. O'Rourke, J. B. McCarthy, and M. F. Mescher. 1997. Cytotoxic T-lymphocyte interaction with fibronectin and vitronectin: activated adhesion and cosignaling. Immunology 91:186.
28. Sturmhofel, K., C. Brando, F. Martinon, E. M. Shevach, and J. E. Coligan. 1995. Antigen-independent, integrin-mediated T cell activation. J. Immunol. 154:2104.
29. 7 signaling pathways. J. Immunol. 157:700.
30. 1, (CD49d/CD29) integrin costimulation of human T cells enhances transcription factor and cytokine induction in the absence of altered sensitivity to anti-CD3 stimulation. J. Immunol. 157:1965.
31. Rosales, C., and R. L. Juliano. 1995. Signal transduction by cell adhesion receptors in leukocytes. J. Leukocyte Biol. 57:189.
32. Roberts, D. D., J. Cashel, and N. Guo. 1994. Purification of thrombospondin from human platelets. J. Tissue Culture Methods 16:217.
33. Akiyama, S. K., S. S. Yamada, W. T. Chen, and K. M. Yamada. 1989. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J. Cell Biol. 109:863.
34. Hemler, M. E., F. Sanchez-Madrid, T. J. Flotte, A. M. Krensky, S. J. Burakoff, A. K. Bhan, T. A. Springer, and J. L. Strominger. 1984. Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J. Immunol. 132:3011.
35. Zhang, W., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, and L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83.
36. Gillis, S., and J. Watson. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152:1709.
37. Landgren, U. 1984. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase: applications to detection of lymphokines and cell surface antigens. J. Immunol. Methods 67:379.
38. Guo, N. H., H. C. Krutzsch, T. Vogel, and D. D. Roberts. 1992. Interactions of a laminin-binding peptide from a 33-kDa protein related to the 67-kDa laminin receptor with laminin and melanoma cells are heparin-dependent. J. Biol. Chem. 267:17743.
39. Taylor, S. J., and D. Shalloway. 1996. Cell cycle-dependent activation of Ras. Curr. Biol. 6:1621.
40. Butscher, W. G., C. Powers, M. Olive, C. Vinson, and K. Gardner. 1998. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2. J. Biol. Chem. 273:552.
41. Duncan, R., I. Collins, T. Tomonaga, T. Zhang, and D. Levens. 1996. A unique transactivation sequence motif is found in the carboxyl-terminal domain of the single-slrand-binding protein FBP. Mol. Cell. Biol. 16:2274.
42. Gorman, C. 1985. DNA Cloning. D. M. Glover, ed. IRL Press, Oxford, p. 143.
43. Dawson, D. W., S. F. Pearce, R. Zhong, R. L. Silverstein, W. A. Frazier, and N. P. Bouck. 1997. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138:707.
44. Frazier, W. A., A.-G. Gao, J. Dimitry, J. Chung, E. J. Brown, F. P. Lindberg, and M. E. Linder 1999. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric G,. J. Biol. Chem. 274:8554.
45. Guo, N., V. S. Zabrenetzky, L. Chandrasekaran, J. M. Sipes, J. Lawler, H. C. Krutzsch, and D. D. Roberts. 1998. Differential roles of protein kinase C and pertussis toxin-sensitive G-binding proteins in modulation of melanoma cell proliferation and motility by thrombospondin-1. Cancer Res. 58:3154.
46. 3 ligands to promote melanoma cell spreading and focal adhesion formation. J. Biol. Chem. In press.
47. Couchman, J. R., and A. Woods. 1996. Syndecans, signaling, and cell adhesion. J. Cell. Biochem. 61:578.
48. Rapraeger, A. 1989. Transforming growth factor (type β) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. J. Cell Biol. 109:2509.
49. Lebakken, C. S., and A. C. Rapraeger. 1996. Syndecan-1 mediates cell spreading in transfected human lymphoblastoid (Raji) cells. J. Cell Biol. 132:1209.
50. Oh, E. S., A. Woods, and J. R. Couchman. 1997. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J. Biol. Chem. 272:8133.
51. 3,. J. Biol. Chem. 272:14740.
52. Cantrell, D. 1996. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 14:259.
53. Van den Brink, M. R., R. Kapeller, J. C. Pratt, J. H. Chang, and S. J. Burakoff. 1999. The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells. J. Biol. Chem. 274:11178.
54. Taraboletti, G., D. Roberts, L. A. Liotta, and R. Giavazzi. 1990. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111:765.
55. Guo, N., H. C. Krutzsch, J. K. Inman, and D. D. Roberts. 1997. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res. 57:1735.
56. Tolsma, S. S., O. V. Volpert, D. J. Good, W. A. Frazier, P. J. Polverini, and N. Bouck. 1993. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122:497.